Acorah Software Products - Accounts Production 18.1.200 true true false true No description of principal activity 22 July 2024 31 July 2025 31 July 2025 15852325 Dr Ahmed Ismail Dr Ahmed Ismail iso4217:GBP iso4217:EUR iso4217:USD xbrli:shares xbrli:pure xbrli:pure 15852325 2024-07-21 15852325 2025-07-31 15852325 2024-07-22 2025-07-31 15852325 frs-bus:PrivateLimitedCompanyLtd 2024-07-22 2025-07-31 15852325 frs-bus:FilletedAccounts 2024-07-22 2025-07-31 15852325 frs-bus:Micro-entities 2024-07-22 2025-07-31 15852325 frs-bus:EntityHasNeverTraded 2024-07-22 2025-07-31 15852325 frs-bus:AuditExempt-NoAccountantsReport 2024-07-22 2025-07-31 15852325 frs-bus:Director1 2024-07-22 2025-07-31 15852325 frs-bus:Director2 2024-07-22 2025-07-31
Registered number: 15852325
Q Clinics International Ltd
Unaudited Financial Statements
For the Period 22 July 2024 to 31 July 2025
Q Clinics International Ltd
Balance Sheet
As At 31 July 2025
Balance Sheet
Registered number: 15852325

| 31 July 2025
--- | ---
|  | £
Current assets |  | 100
NET CURRENT ASSETS |  | 100
TOTAL ASSETS LESS CURRENT LIABILITIES |  | 100
NET ASSETS |  | 100
CAPITAL AND RESERVES |  | 100

## Notes

1. General Information
Q Clinics International Ltd is a private company, limited by shares, incorporated in England & Wales, registered number 15852325 . The registered office is First Floor, 244 Edgware Road, London, W2 1DS.
2. Average Number of Employees
Average number of employees, including directors, during the period was: NIL
-
Page 0
Page 1
Q Clinics International Ltd
Balance Sheet (continued)
As At 31 July 2025
For the period ending 31 July 2025 the company was entitled to exemption from audit under section 480 of the Companies Act 2006 relating to dormant companies.
The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared in accordance with the micro-entity provisions and delivered in accordance with the provisions applicable to companies subject to the small companies regime.
On behalf of the board

Dr Ahmed Ismail Director
21 April 2026